Home/Filings/4/0001628280-25-010136
4//SEC Filing

Verratti Mark 4

Accession 0001628280-25-010136

CIK 0000899923other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 7:31 PM ET

Size

5.0 KB

Accession

0001628280-25-010136

Insider Transaction Report

Form 4
Period: 2025-02-07
Verratti Mark
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2025-02-07+12,758302,035 total
Footnotes (1)
  • [F1]Consists of performance-based restricted stock units (PSUs) initially granted on March 22, 2022, subject to accomplishment of pre-determined performance metrics. On February 7, 2025, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 22, 2025.

Issuer

MYRIAD GENETICS INC

CIK 0000899923

Entity typeother

Related Parties

1
  • filerCIK 0001517026

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:31 PM ET
Size
5.0 KB